Discovery of a Novel, Isothiazolonaphthoquinone-Based Small Molecule Activator of FOXO Nuclear-Cytoplasmic Shuttling.
FOXO factors are tumour suppressor proteins commonly inactivated in human tumours by posttranslational modifications. Furthermore, genetic variation within the FOXO3a gene is consistently associated with human longevity. Therefore, the pharmacological activation of FOXO proteins is considered as an...
Main Authors: | Bastien Cautain, Francisco Castillo, Loana Musso, Bibiana I Ferreira, Nuria de Pedro, Lorena Rodriguez Quesada, Susana Machado, Francisca Vicente, Sabrina Dallavalle, Wolfgang Link |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5147912?pdf=render |
Similar Items
-
Natural Compound-derived Cytochrome bc1 Complex Inhibitors as Antifungal Agents
by: Loana Musso, et al.
Published: (2020-10-01) -
Maturation and nucleo-cytoplasmic shuttling of snRNAs in Saccharomyces cerevisiae
by: Becker, Daniel
Published: (2019) -
Small Molecule Inhibitors of CRM1
by: Bibiana I. Ferreira, et al.
Published: (2020-05-01) -
High cytoplasmic FOXO1 and pFOXO1 expression in astrocytomas are associated with worse surgical outcome.
by: Chao Chen, et al.
Published: (2013-01-01) -
Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.
by: Brian J North, et al.
Published: (2007-08-01)